Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Guardian Pharmacy Services, Inc. Class A ( (GRDN) ).
On May 9, 2025, Guardian Pharmacy Services, Inc. held its Annual Meeting of Stockholders, where key decisions were made regarding the company’s leadership and financial oversight. The stockholders elected Class I directors to serve until 2028, including David Morris, Mary Sue Patchett, and Thomas Salentine, Jr. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 was ratified by the stockholders.
The most recent analyst rating on (GRDN) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Guardian Pharmacy Services, Inc. Class A stock, see the GRDN Stock Forecast page.
Spark’s Take on GRDN Stock
According to Spark, TipRanks’ AI Analyst, GRDN is a Neutral.
Guardian Pharmacy Services, Inc. presents a mixed picture. Strong revenue growth and positive guidance improve the outlook, yet significant profitability and leverage challenges remain. The technical analysis signals a short-term upward trend, but valuation is difficult to assess due to missing key metrics. Overall, the stock’s strengths in growth are countered by financial and valuation uncertainties, resulting in a moderate stock score.
To see Spark’s full report on GRDN stock, click here.
More about Guardian Pharmacy Services, Inc. Class A
Average Trading Volume: 86,226
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.62B
For detailed information about GRDN stock, go to TipRanks’ Stock Analysis page.